292 related articles for article (PubMed ID: 22325939)
1. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.
El-Hattab AW; Hsu JW; Emrick LT; Wong LJ; Craigen WJ; Jahoor F; Scaglia F
Mol Genet Metab; 2012 Apr; 105(4):607-14. PubMed ID: 22325939
[TBL] [Abstract][Full Text] [Related]
2. Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation.
El-Hattab AW; Emrick LT; Hsu JW; Chanprasert S; Almannai M; Craigen WJ; Jahoor F; Scaglia F
Mol Genet Metab; 2016 Apr; 117(4):407-12. PubMed ID: 26851065
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Nitric Oxide Production in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome with the Use of a Stable Isotope Tracer Infusion Technique.
El-Hattab AW; Jahoor F
J Nutr; 2017 Jul; 147(7):1251-1257. PubMed ID: 28515163
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.
El-Hattab AW; Emrick LT; Chanprasert S; Craigen WJ; Scaglia F
Int J Biochem Cell Biol; 2014 Mar; 48():85-91. PubMed ID: 24412347
[TBL] [Abstract][Full Text] [Related]
5. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders.
El-Hattab AW; Emrick LT; Craigen WJ; Scaglia F
Mol Genet Metab; 2012 Nov; 107(3):247-52. PubMed ID: 22819233
[TBL] [Abstract][Full Text] [Related]
6. The effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome.
El-Hattab AW; Emrick LT; Williamson KC; Craigen WJ; Scaglia F
Meta Gene; 2013 Dec; 1():8-14. PubMed ID: 25411654
[TBL] [Abstract][Full Text] [Related]
7. Arginine and citrulline for the treatment of MELAS syndrome.
El-Hattab AW; Almannai M; Scaglia F
J Inborn Errors Metab Screen; 2017 Jan; 5():. PubMed ID: 28736735
[TBL] [Abstract][Full Text] [Related]
8. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
El-Hattab AW; Adesina AM; Jones J; Scaglia F
Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
[TBL] [Abstract][Full Text] [Related]
9. Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox".
Naini A; Kaufmann P; Shanske S; Engelstad K; De Vivo DC; Schon EA
J Neurol Sci; 2005 Mar; 229-230():187-93. PubMed ID: 15760638
[TBL] [Abstract][Full Text] [Related]
10. Heteroplasmic pathogenic m.12315G>A variant in MT-TL2 presenting with MELAS syndrome and depletion of nitric oxide donors.
Snyder MT; Manor J; Gijavanekar C; Mizerik E; Kralik SF; Elsea SH; Machol K; Emrick L; Scaglia F
Am J Med Genet A; 2024 Mar; 194(3):e63461. PubMed ID: 37953071
[TBL] [Abstract][Full Text] [Related]
11. L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.
Rodan LH; Wells GD; Banks L; Thompson S; Schneiderman JE; Tein I
PLoS One; 2015; 10(5):e0127066. PubMed ID: 25993630
[TBL] [Abstract][Full Text] [Related]
12. The utility of arginine-citrulline stable isotope tracer infusion technique in the assessment of nitric oxide production in MELAS syndrome.
El-Hattab AW; Jahoor F
Int J Cardiol; 2018 Mar; 254():282. PubMed ID: 28843720
[No Abstract] [Full Text] [Related]
13. Two different approaches to restore renal nitric oxide and prevent hypertension in young spontaneously hypertensive rats: l-citrulline and nitrate.
Chien SJ; Lin KM; Kuo HC; Huang CF; Lin YJ; Huang LT; Tain YL
Transl Res; 2014 Jan; 163(1):43-52. PubMed ID: 24113064
[TBL] [Abstract][Full Text] [Related]
14. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.
Ganetzky RD; Falk MJ
Mol Genet Metab; 2018 Mar; 123(3):301-308. PubMed ID: 29428506
[TBL] [Abstract][Full Text] [Related]
15. Nitric Oxide Deficiency in Mitochondrial Disorders: The Utility of Arginine and Citrulline.
Almannai M; El-Hattab AW
Front Mol Neurosci; 2021; 14():682780. PubMed ID: 34421535
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction in MELAS improved by l-arginine supplementation.
Koga Y; Akita Y; Junko N; Yatsuga S; Povalko N; Fukiyama R; Ishii M; Matsuishi T
Neurology; 2006 Jun; 66(11):1766-9. PubMed ID: 16769961
[TBL] [Abstract][Full Text] [Related]
17. Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production.
Luiking YC; Poeze M; Ramsay G; Deutz NE
Am J Clin Nutr; 2009 Jan; 89(1):142-52. PubMed ID: 19056593
[TBL] [Abstract][Full Text] [Related]
18. Arginine Supplementation in MELAS Syndrome: What Do We Know about the Mechanisms?
Barros CDS; Coutinho A; Tengan CH
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612442
[TBL] [Abstract][Full Text] [Related]
19. Arginine, citrulline and nitric oxide metabolism in sepsis.
Kao CC; Bandi V; Guntupalli KK; Wu M; Castillo L; Jahoor F
Clin Sci (Lond); 2009 Jun; 117(1):23-30. PubMed ID: 19105791
[TBL] [Abstract][Full Text] [Related]
20. l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells.
Winnica D; Que LG; Baffi C; Grasemann H; Fiedler K; Yang Z; Etling E; Wasil K; Wenzel SE; Freeman B; Holguin F
Clin Exp Allergy; 2017 Feb; 47(2):190-199. PubMed ID: 27562295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
